Genocea Provides Fourth Quarter 2021 Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. UNH
7. CVS
8. SBUX
9. AXP
10. ZETA

Go back to Genocea Provides Fourth Quarter 2021 Corporate Update

Genocea Biosciences (GNCA) Tops Q4 EPS by 1c

March 10, 2022 7:01 AM EST

Genocea Biosciences (NASDAQ: GNCA) reported Q4 EPS of ($0.19), $0.01 better than the analyst estimate of ($0.20).

Genoceas existing cash is sufficient to support our current operations into Q3 2022, however we have strategic plans to extend our operations into 2023.

For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.

... More